Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_assertion type Assertion NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_head.
- NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_assertion description "[This retrospective study was aimed to investigate the efficacy of prophylactic agents in hepatocellular carcinoma (HCC) patients receiving TACE and compare the difference between lamivudine and entecavir.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_provenance.
- NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_assertion evidence source_evidence_literature NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_provenance.
- NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_assertion SIO_000772 25520081 NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_provenance.
- NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_assertion wasDerivedFrom befree-2016 NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_provenance.
- NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_assertion wasGeneratedBy ECO_0000203 NP1249071.RADGGgt4_lYJGz9UYv2CA2lwX5DXXzvbZoHajFVsL3-hc130_provenance.